The oxidized low-density lipoprotein/β2-glycoprotein I complex is associated with abdominal obesity in healthy middle-aged men

Annals of Nutrition and Metabolism

Volumn 62, Issue 1, 2013, Pages 7-13

  Kraml, Pavel J ^a   Syrovátka, Petr ^b   Potočková, Jana ^a   Anděl, Michal ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Endothelial function; Inflammation; Insulin resistance; Oxidized low density lipoprotein

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; BETA2 GLYCOPROTEIN 1; INTERLEUKIN 8; OXIDIZED LOW DENSITY LIPOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; THIOREDOXIN;

ABDOMINAL OBESITY; ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BODY MASS; CLINICAL ARTICLE; COMMON CAROTID ARTERY; CONTROLLED STUDY; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MALE; MIDDLE AGED; OXIDATIVE STRESS; PRIORITY JOURNAL; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

EID: 84869211463     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000343049     Document Type: Article

References (35)

1. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716
2. Obunai K, Jani S, Dangas GD. Cardiovascular morbidity and mortality of the metabolic syndrome. Med Clin North Am 2007; 91: 1169-1184
3. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607
4. Xu H, Barnes GT, Yang Q, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112: 1821-1830
5. Lemieux I, Pascot A, Prud'homme D, Alméras N, Bogoty P, Nadeau A, Bergeron J, Despreés JP. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol 2001; 21: 961-967
6. Calabro P, Golia E, Maddaloni V, Casillio B, Marotta C, Calabró R, Golino P. Adipose tissue-mediated inflammation: the missing link between obesity and cardiovascular disease?. Intern Emerg Med 2009; 4: 25-34
7. Nishida M, Moriyama T, Sugita Y, Yamauchi-Takihara K. Abdominal obesity exhibits distinct effect on inflammatory and anti-inflammatory proteins in apparently healthy Japanese men. Cardiovasc Diabetol 2007; 6: 27
8. Ross R. Atherosclerosis -an inflammatory disease. N Engl J Med 1999; 340: 115-126
9. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915-924
10. Murphy JE, Tedbury PR, Homer-Vanniasinkam S, Walker JH, Ponnambalam S. Biochemistry and cell biology of mammalian scavenger receptors. Atherosclerosis 2005; 182: 1-15
11. Hasunuma Y, Matsuura E, Makita Z, Katahira T, Nishi S, Koike T. Involvement of beta 2-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophages. Clin Exp Immunol 1997; 107: 569-573
12. Hörkkö S, Olee T, Mo L, Branch W, Woods VL Jr, Palinski W, Chen JP, Witztum JL. Anticardiolipin antibodies from patients with the antiphospholipid antibody syndrome recognize epitopes in both2-glycoprotein 1 and oxidized low-density lipoprotein. Circulation 2001; 103: 941-946
13. Kajiwara T, Yasuda T, Matsuura E. Intracellular trafficking of2-glycoprotein I complexes with lipid vesicles in macrophages: implication on the development of antiphospholipid syndrome. J Autoimmun 2007; 29: 164-173
14. George J, Harats D, Gilburd B, Afek A, Levy Y, Schneiderman J, Barshack I, Kopolovic J, Shoenfeld Y. Immunolocalization of2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques. Circulation 1999; 99: 2227-2230
15. Ylä-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Buttler S, Witztum JL, Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 1989; 85: 1086-1095
16. Lopez LR, Simpson DF, Hurley BL, Matsuura E. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement. Ann NY Acad Sci 2005; 1051: 313-322
17. Lopez LR, Hurley BL, Simpson DF, Matsuura E. Oxidized low-density lipoprotein/beta2GPI complexes and antibodies in patients with type 2 diabetes mellitus. Ann NY Acad Sci 2005; 1051: 97-103
18. Kasahara J, Kobayashi K, Maeshima Y, Yamasaki Y, Yasuda T, Matsuura E, Makino H. Clinical significance of serum oxidized low-density lipoprotein/2-glycoprotein I complexes in patients with chronic renal diseases. Nephron Clin Pract 2004; 98:c15-c24
19. Greco TP, Conti-Kelly AM, Anthony JR, Greco T Jr, Doyle R, Boisen M, Kojima K, Matsuura E, Lopez LR. Oxidized-LDL/2-glycoprotein I complexes are associated with disease severity and increased risk for adverse outcomes in patients with acute coronary syndromes, Am J Clin Pathol 2010; 133: 737-743
20. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group: The metabolic syndrome -a new worldwide definition. Lancet 2005; 366: 1059-1062
21. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998; 21: 2191-2192
22. Dobiasova M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). Clin Biochem 2001; 34: 583-588
23. Witko-Sarsat V, Friedlander M, Capeillere-Blandin CH, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Desscamps-Latscha B. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996; 49: 1304-1314
24. Nakamura T, Sato E, Fujiwara N, Kawagoe Y, Yamada S, Ueda Y, Koide H. Changes in urinary albumin excretion, inflammatory and oxidative stress markers in ADPKD patients with hypertension. Am J Med Sci 2012; 343: 46-51
25. Frey RS, Ushio-Fukai M, Malik AB. NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology. Antioxid Redox Signal 2009; 11: 791-810
26. Virdis A, Neves MF, Amiri F, Touyz RM, Schiffrin EL. Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice. J Hypertens 2004; 22: 535-542
27. Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 1997; 46: 860-867
28. Cesari M, Pahor M, Incalzi RA. Plasminogen activator inhibitor-I (PAI-I): a key factor linking fibrinolysis and age related subclinical and clinical conditions. Cardiovasc Ther 2010; 28:e72-e91
29. Krone KA, Allen KL, McCrae KR. Impaired fibrinolysis in the antiphospholipid syndrome. Curr Rheumatol Rep 2010; 12: 53-57
30. Bu C, Gao L, Xie W, Zhang J, He Y, Cai G, McCrae KR:2-Glycoprotein I is a cofactor for tissue plasminogen activator-mediated plasminogen activation. Arthritis Rheum 2009; 60: 559-568
31. Ieko M, Ichikawa K, Atsumi T, Takeuchi R, Sawada KI, Yasukouchi T, Koike T. Effects of beta-2 glycoprotein I and monoclonal anticardiolipin antibodies on extrinsic fibrinolysis. Semin Thromb Hemost 2000; 26: 85-90
32. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004; 145: 2273-2282
33. Vlahopoulos S, Boldogh I, Casola A, Brasier AR. Nuclear factor-kappaB-dependent induction of interleukin-8 gene expression by tumor necrosis factor alpha: evidence for an antioxidant sensitive activating pathway distinct from nuclear translocation. Blood 1999; 94: 1878-1889
34. Bruun JM, Pedersen SB, Kristensen K, Richelsen B. Opposite regulation of interleukin 8 and tumor necrosis factor-alpha in weight loss. Obes Res 2002; 10: 499-506
35. Staiger H, Wöll J, Haas C, Machicao F, Schleicher ED, Fritsche A, Stefan N, Häring HV. Selective association of plasma non-esterified fatty acids species with circulating interleukin-8 concentrations in humans. Exp Clin Endocrinol Diabetes 2009; 117: 21-27